Company intelligence / Profile preview

MyChem

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

MyChem specializes in providing high-purity nucleotides used as critical raw materials in mRNA synthesis and other therapeutic, diagnostic, and research applications. The company was acquired by Maravai LifeSciences to strengthen its cell and gene therapy raw materials offering and enable integrated supply for mRNA technology.[1][3][4]

Modalities: Small moleculeNucleotideModified nucleotide
Industry: Chemicals & Materials

Partnerships

Maravai LifeSciencesTriLink Biotechnologies

Beyond the preview

Go deeper on MyChem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyChem.

Explore the full profile